Litcius/Paper detail

Efficacy and Safety of Nivolumab in Previously Treated Patients With Non–Small-cell Lung Cancer: Real World Experience in Argentina

Claudio Martín, Lorena Lupinacci, Florencia Perazzo, Carlos Bas, Omar Carranza, Carmen Puparelli, Rubén Dario Kowalyszyn, Ignacio Magrí, Mirta Varela, Eduardo Richardet, Karina Vera, Silvia Foglia, Ignacio Jerez, Enrique Aman, Gastón Lucas Martinengo, Emilio Batagelj, Alejandro Dri, N. Pilnik, Guillermo M. Roa, Pablo Mandó, Florencia Tsou, Gonzálo Recondo, Federico Cayol, Marcos A. Flores, S. Sena, Claudia Bagnes, Federico Waisberg, J.N. Minatta, Manglio Rizzo

2020Clinical Lung Cancer23 citationsDOI

Topics & Concepts

MedicineNivolumabInternal medicineLung cancerInterquartile rangeHazard ratioOncologyToxicityRetrospective cohort studyChemotherapyUnivariate analysisProgressive diseaseSurgeryCancerMultivariate analysisConfidence intervalImmunotherapyCancer Immunotherapy and BiomarkersLung Cancer Diagnosis and TreatmentCAR-T cell therapy research
Efficacy and Safety of Nivolumab in Previously Treated Patients With Non–Small-cell Lung Cancer: Real World Experience in Argentina | Litcius